The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
aveo pharmaceuticals | 252 |
xoma technology | 31 |
osi pharmaceuticals | 4 |
biodesix | 3 |
aveo pharmaceuticals | 24 |
xoma technology | 5 |
aveo pharmaceuticals | 11 |
osi pharmaceuticals | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
hepatocyte growth factor (hgf) binding proteins | 67 | 2006 |
anti-erbb3 antibodies | 35 | 2010 |
anti-fgfr2 antibodies | 19 | 2010 |
anti-gdf15 antibodies | 18 | 2012 |
predicting tumor response to anti-erbb3 antibodies | 17 | 2011 |
anti-ron antibodies | 12 | 2010 |
tivozanib and temsirolimus in combination | 11 | 2009 |
tivozanib response prediction | 11 | 2009 |
treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator | 9 | 2014 |
tivozanib response prediction | 9 | 2009 |